UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031645
Receipt number R000036129
Scientific Title Clinical trial related with transplantation therapy with human autologous cell mixed sheets for refractory cutaneous ulcer
Date of disclosure of the study information 2018/03/09
Last modified on 2021/03/11 10:39:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial related with transplantation therapy with human autologous cell mixed sheets for refractory cutaneous ulcer

Acronym

Autologous cell mixed sheets transplantation for refractory cutaneous ulcer

Scientific Title

Clinical trial related with transplantation therapy with human autologous cell mixed sheets for refractory cutaneous ulcer

Scientific Title:Acronym

Autologous cell mixed sheets transplantation for refractory cutaneous ulcer

Region

Japan


Condition

Condition

refractory cutaneous ulcer

Classification by specialty

Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify safety of transplantation therapy with human autologous cell mixed cell sheet which consist of fibroblasts and peripheral blood mononuclear cells for patients with refractory cutaneous ulcer

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Presence or absence, frequency, and severity of all adverse events

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Therapeutic angiogenesis using autologous bone marrow mononuclear cell

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients not adequate for conventional therapy.
2. Patients with wound area of cutaneous ulcers which is covered with cell sheets enough.
3. Patients can provide written informed consent for study participation.
4. Patients with venous reflux detected by air plethysmography or ultrasound.

Key exclusion criteria

1. Patients suffering from critical limb ischemia.
2. Patients suffering from malignant neoplasm.
3. Patients suffering from bacterial infections such as treponema palladium, chlamydia, gonorrhea and tuberculosis.
4. Patients suffering from infections such as hepatitis B and C viruses, human immunodeficiency virus, human T lymphotropic virus type 1 and parvovirus B19.
5. Patients with allergy of local anesthesia.
6. Hemoglobin: < 8.0 g/dL, Plt: < 50,000 /uL, Prothrombin time: < 40%
7. Patients with sepsis or suspected with.
8. Patients with congenital coagulopathy, antiplatelet drug use, or anticoagulant use.
9. Patients who have experienced other cell or gene therapy
10. Patients who join other clinical trials or joined them within 6 months.
11. Patients with hemodialysis.
12. Patients who developed unstable angina, myocardial ischemia, or cerebral infarction within 3 months
13. Pregnant woman and women who may possibly be pregnant, women in nursing
14. Patients with allergy of aminoglycoside antibiotics.
15. Patient determined to be ineligible for this clinical study by research attending physician.

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Hamano
Middle name
Last name Kimikazu

Organization

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine

Division name

Division of first surgery

Zip code

755-8505

Address

Ube, 755-8505, Japan

TEL

0836-22-2261

Email

tmizo@yamaguchi-u.ac.jp


Public contact

Name of contact person

1st name Takahiro
Middle name
Last name Mizoguchi

Organization

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine

Division name

Division of first surgery

Zip code

755-8505

Address

Ube, 755-8505, Japan

TEL

0836-22-2261

Homepage URL


Email

tmizo@yamaguchi-u.ac.jp


Sponsor or person

Institute

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamaguchi university clinical research center

Address

Ube, 755-8505, Japan

Tel

0836-22-2428

Email

me223@yamaguchi-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

6

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 12 Month 05 Day

Date of IRB

2017 Year 11 Month 29 Day

Anticipated trial start date

2018 Year 03 Month 05 Day

Last follow-up date

2021 Year 03 Month 04 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 09 Day

Last modified on

2021 Year 03 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036129


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name